BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CiviCRM//NONSGML CiviEvent iCal//EN
X-WR-TIMEZONE:Europe/London
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261207T143000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:CiviCRM_EventID_2017_e86a4f28f24ec85011f2b11344e0bb4c@onenucleus.com
SUMMARY:Dealmaking with China in Bio-Innovation
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC
  "-//W3C//DTD HTML 3.2//EN"><html><body><p>China h
 as transformed rapidly to become a major global bi
 o-innovation hub significantly impacting how the e
 stablished life science innovation ecosystems of t
 he West are evolving and pursuing collaboration an
 d dealmaking with their Chinese counterparts. The 
 seminar will look at the issues impacting innovati
 on\, value creation and dealmaking dynamics with C
 hina.<br />\n <br />\n <strong>Agenda</strong>:<br
  />\n 14.30: Delegate registration and networking<
 br />\n 15.00: Impressions of China from a bio-ent
 repreneur<br />\n Renos Savva\, Discovery Park<br 
 />\n 15:25 Protecting and managing IP to attract a
  Chinese investor<br />\n Amanda Simons\, J A Kemp
 <br />\n 15.50  Navigating the China Biopharma Dea
 lmaking Process<br />\n Pingjun Wei\, Verdiva Bio<
 br />\n 16.10 Q&A with the speakers<br />\n 16.30 
  Closing Remarks<br />\n 16.35  Networking of drin
 ks<br />\n 18.00  Close</p>\n \n <p><img alt="imag
 e-20261013120520-2.jpeg" src="https://onenucleus.c
 om/sites/default/files/civicrm/persist/contribute/
 images/image-20261013120520-2.jpeg" style="width:1
 50px\;height:24px\;" />  <img alt="image-202610131
 20445-1.png" src="https://onenucleus.com/sites/def
 ault/files/civicrm/persist/contribute/images/image
 -20261013120445-1.png" style="width:250px\;height:
 100px\;" /><br />\n <br />\n <strong>Registration:
  Free to attend subject to availability with pre-r
 egistration essential.</strong></p></body></html>
DESCRIPTION:China has transformed rapidly to become a major gl
 obal bio-innovation hub significantly impacting ho
 w the established life science innovation ecosyste
 ms of the West are evolving and pursuing collabora
 tion and dealmaking with their Chinese counterpart
 s. The seminar will look at the issues impacting i
 nnovation\, value creation and dealmaking dynamics
  with China.\n \n \n \n Agenda:\n \n 14.30: Delega
 te registration and networking\n \n 15.00: Impress
 ions of China from a bio-entrepreneur\n \n Renos S
 avva\, Discovery Park\n \n 15:25 Protecting and ma
 naging IP to attract a Chinese investor\n \n Amand
 a Simons\, J A Kemp\n \n 15.50  Navigating the Chi
 na Biopharma Dealmaking Process\n \n Pingjun Wei\,
  Verdiva Bio\n \n 16.10 Q&A with the speakers\n \n
  16.30  Closing Remarks\n \n 16.35  Networking of 
 drinks\n \n 18.00  Close\n \n \n \n   \n \n \n \n 
 Registration: Free to attend subject to availabili
 ty with pre-registration essential.\n \n 
CATEGORIES:Events
CALSCALE:GREGORIAN
DTSTAMP;TZID=Europe/London:20261207T143000
DTSTART;TZID=Europe/London:20261207T143000
DTEND;TZID=Europe/London:20261207T180000
LOCATION:J A Kemp LLP\n 80 Turnmill Street\n  EC1M 5QU\n Un
 ited Kingdom\n 
URL:https://onenucleus.com/civicrm/event/info?reset=1&id=2017
END:VEVENT
END:VCALENDAR